Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May:8:e2100357.
doi: 10.1200/GO.21.00357.

Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence

Affiliations
Review

Impact of COVID-19 Disease in Early Breast Cancer Management: A Summary of the Current Evidence

Francisco Pimentel Cavalcante et al. JCO Glob Oncol. 2022 May.

Abstract

Purpose: An expert panel on breast cancer and COVID-19 disease was convened to address the impact of the COVID-19 pandemic for early breast cancer (eBC) management.

Methods: To ensure that the most clinically relevant information was addressed, essential information was drawn from several of the latest national and international guidelines and another technical document. The expert panel met in five virtual closed sessions from November 2020 to May 2021 to consult on the relevant data from evidence-based results. The data gathered were discussed on an online platform.

Results: This article reports the expert panel's highlights of these meetings' discussions. In addition, it provides practical recommendations covering topics regarding diagnosis, treatment, and management of patients with eBC in clinical settings routinely encountered by health care professionals amid the COVID-19 pandemic.

Conclusion: This article provided guidance on several topics regarding eBC management amid the COVID-19 pandemics to inform safer care practices.

PubMed Disclaimer

Conflict of interest statement

Francisco Pimentel CavalcanteConsulting or Advisory Role: Pfizer, Roche, MSD OncologySpeakers' Bureau: Roche, Pfizer, Gencell Pharma, LibbsTravel, Accommodations, Expenses: Roche, Gencell Pharma Carlos Eduardo dos Santos FerreiraSpeakers' Bureau: Roche Diagnostica Brasil, Beckman Coulter, Abbott Diagnostics Gilberto AmorimStock and Other Ownership Interests: Pfizer, AstraZenecaHonoraria: Roche, Novartis, Lilly, Sanofi/Aventis, Pfizer, MSD OncologyConsulting or Advisory Role: Novartis, Roche, MSD OncologyTravel, Accommodations, Expenses: Roche, Novartis Luciana LandeiroConsulting or Advisory Role: GlaxoSmithKline Álvaro Pulchinelli JrConsulting or Advisory Role: Roche, Thermo Fisher Scientific, bioMerieux, BD Biosciences Daniela Dornelles RosaConsulting or Advisory Role: Roche, Novartis, AstraZeneca, Lilly, GlaxoSmithKline, Sanofi, Libbs, Pfizer, Amgen, Zodiac PharmaSpeakers' Bureau: Novartis, Lilly, PfizerTravel, Accommodations, Expenses: RocheNo other potential conflicts of interest were reported.

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
    1. Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33. - PubMed
    1. Aguiar S, Baiocchi G, Duprat JP, et al. Value of preoperative testing for SARS-CoV-2 for elective surgeries in a cancer center during the peak of pandemic in Brazil. J Surg Oncol. 2020;122:1293–1295. - PMC - PubMed
    1. Cavalcante FP, Novita GG, Millen EC, et al. Management of early breast cancer during the COVID-19 pandemic in Brazil. Breast Cancer Res Treat. 2020;184:637–647. - PMC - PubMed
    1. Papautsky EL, Hamlish T. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic. Breast Cancer Res Treat. 2020;184:249–254. - PMC - PubMed